The Chemotherapy Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of chemotherapy has experienced a swift expansion in the past few years. The sector, worth $34 billion in 2024, is projected to escalate to $37.78 billion in 2025, with a compound annual growth rate (CAGR) of 11.1%.
The market size for chemotherapy is predicted to reach $62.22 billion in 2029, expanding at a compound annual growth rate (CAGR) of 13.3%.
Download Your Free Sample of the 2025 Chemotherapy Market Report and Uncover Key Trends Now!The key drivers in the chemotherapy market are:
• Integration of immunotherapy into treatment plans
• Adoption of biosimilar drugs
• Expansion into emerging markets
• Advances in genomic profiling and supportive care
The chemotherapy market covered in this report is segmented –
1) By Product Type: Pump, Cannula, Catheter, Other Product Types
2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer
3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs
4) By Route Of Administration: Oral, Intravenous
5) By End User: Hospitals, Research Institutes, Other End Users
The key trends in the chemotherapy market are:
• The integration of digital health solutions is an emerging trend.
• There is a notable shift towards personalized medicine in chemotherapy.
• Continued focus on oncology research is increasingly shaping the chemotherapy market.
• The potential use of AI and advancements in nanotechnology are evolving trends.
Major companies in the chemotherapy market are:
• GlaxoSmithKline plc
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd.
• Novartis AG
• Pfizer Inc.
• Merck & Co Inc.
• Sanofi SA
• Celgene Corporation
• Bristol-Myers Squibb Company
• Amgen Inc.
• Bayer AG
• Almatic Pharma LLC
• AstraZeneca Pharmaceuticals
• Astellas Pharma Inc.
• Puma Biotechnology Inc.
• Clovis Oncology Inc.
• Takeda Pharmaceutical Company Limited
• Johnson & Johnson Services Inc.
• Mylan NV
• Teva Pharmaceutical Industries Ltd.
• AbbVie Inc.
• Gilead Sciences Inc.
• Biogen Inc.
• Eisai Co. Ltd.
• Ipsen SA
• Spectrum Pharmaceuticals Inc.
• Seattle Genetics Inc.
• Exelixis Inc.
• Karyopharm Therapeutics Inc.
• Incyte Corporation
• Agios Pharmaceuticals Inc.
• Epizyme Inc.
• Blueprint Medicines Corporation
• Array BioPharma Inc.
• BeiGene Ltd.
• Halozyme Therapeutics Inc.
• MacroGenics Inc.
• Immunomedics Inc.
• TG Therapeutics Inc.
• Verastem Inc.
North America was the largest region in the chemotherapy market in 2024